The total return over the past 12 months is -27.16% vs. +16.94% for the S&P 500. So far it's up -29.24% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (27.16%) | (8.58%) | (32.33%) | N/A | N/A | N/A |
| Total Return CAGR | (27.16%) | (8.58%) | (32.33%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Sana Biotechnology, Inc. (SANA)
| Year | Start price | End price | SANA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.07 | $2.88 | (29.24%) | +14.51% | (43.75%) |
| 2025 | $1.63 | $4.07 | +149.69% | +17.72% | +131.97% |
| 2024 | $4.08 | $1.63 | (60.05%) | +24.89% | (84.94%) |
| 2023 | $3.95 | $4.08 | +3.29% | +26.19% | (22.90%) |
| 2022 | $15.48 | $3.95 | (74.48%) | (18.17%) | (56.31%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
